Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Larissa Yukari Okada"'
Autor:
Pedro Amoedo Fernandes, Flávia Tobaldini Russo, Lucas Augusto Monetta da Silva, Lafayete William Ferreira Ramos, Aline de Almeida Simões, Larissa Yukari Okada, Jamilla Neves Cavalcante, Maricy Almeida Viol Ferreira Lopes, Maria Cristina Martins de Almeida Macedo, Roberto Luiz da Silva
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 15, Iss 2 (2021)
Background: Patients with hematological disease are 15 times more likely to develop sepsis than the general population. The patient with hematological disease and, mainly, those undergoing hematopoietic stem cell transplantation (HSCT), develop a sev
Externí odkaz:
https://doaj.org/article/0c982e4be69d4f90a3e917ac3160ed0c
Autor:
Flávia Tobaldini Russo, Maria Cristina Martins de Almeida Macedo, Pedro Amoedo Fernandes, Larissa Yukari Okada, Lucas Augusto Monetta da Silva, Camila Menin Simões, Jamilla Neves Cavalcante, Aline de Almeida Simões, Manuella de Souza Sampaio Almeida, Maricy Almeida Viol Ferreira Lopes, Roberto Luiz da Silva
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 14, Iss 2 (2020)
Acute Lymphoblastic Leukemia is a very aggressive malignant disorder of lymphoid cells in adults, with recurrence (30 to 60% of the cases) after the initial treatment. Until this moment, there is no gold standard therapy for the treatment of adult pa
Externí odkaz:
https://doaj.org/article/22a47d186e044d818575fed902ce0479
Autor:
Larissa Yukari Okada, Flavia Tobaldini Russo, Camila Menin Simões, Aline de Almeida Simões, Maricy Almeida Viol Ferreira Lopes, Jamilla Neves Cavalcante, Lucas Augusto Monetta da Silva, Rafael de Almeida Macedo, M. Almeida, Roberto Luiz da Silva, Maria Cristina Martins de Almeida Macedo, Pedro Amoedo Fernandes, Bruna Letícia da Silva Santos Geraldo
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:458-462
Hematopoietic stem cell transplantation (HSCT) has been used to treat many malignant and nonmalignant hematologic conditions; however, the use of HSCT in patients who refuse blood transfusions has rarely been described in the literature, and no data
Autor:
Larissa Yukari Okada, Jamilla Neves Cavalcante, Flavia Tobaldini Russo, Lafayete Willian Ferreira Ramos, Maricy Almeida Viol Ferreira Lopes, Aline de Almeida Simões, Roberto Luiz da Silva, Lucas Augusto Monetta da Silva, Maria Cristina Martins de Almeida Macedo, Pedro Amoedo Fernandes
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 15, Iss 2 (2021)
International Journal of Hematology-Oncology and Stem Cell Research
International Journal of Hematology-Oncology and Stem Cell Research
Background: Patients with hematological disease are 15 times more likely to develop sepsis than the general population. The patient with hematological disease and, mainly, those undergoing hematopoietic stem cell transplantation (HSCT), develop a sev
Autor:
Luana Campos, Andressa Matucci Hotsumi, Ricardo Yudi Tateno, Alyne Simões, Luiz Felipe Palma, Sandra Bastos Rezende, Maria Cristina Martins de Almeida Macedo, Larissa Yukari Okada
Publikováno v:
Photodiagnosis and photodynamic therapy. 34
In hematopoietic cell transplants (HCT) patients, opportunistic fungal infections – especially candidiasis - are typical and, due to the immunosuppressed condition, severe and fatal clinical conditions may occur. Many antifungal agents are used for
Autor:
Larissa Yukari Okada, Pedro Amoedo Fernades, Roberto Luiz da Silva, Maricy Almeida Viol Ferreira Lopes, Flavia Tobaldini Russo, Jamilla Neves Cavalcante, Maria Cristina Martins de Almeida Macedo, Camila Menin Simões, Lucas Augusto Monetta da Silva, M. Almeida, Aline de Almeida Simões
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 14, Iss 2 (2020)
International Journal of Hematology-Oncology and Stem Cell Research
International Journal of Hematology-Oncology and Stem Cell Research
Acute Lymphoblastic Leukemia is a very aggressive malignant disorder of lymphoid cells in adults, with recurrence (30 to 60% of the cases) after the initial treatment. Until this moment, there is no gold standard therapy for the treatment of adult pa